Evidence map›Paper›PMID 24022535›Full record

ArticleDiseases of the colon and rectum2013

Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier.

Shazia Bashir, Cande V Ananth, Sharyn N Lewin, William M Burke, Yu-Shiang Lu, Alfred I Neugut, Thomas J Herzog, Dawn L Hershman, Jason D Wright

Abstract read
In one paragraph

Article in Diseases of the colon and rectum, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shazia Bashir1 Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 2 Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 3 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York 4 Herbert Irving Comprehensive Cancer Center, New York, New York.
Cande V Ananth
Sharyn N Lewin
William M Burke
Yu-Shiang Lu
Alfred I Neugut
Thomas J Herzog
Dawn L Hershman
Jason D Wright
Columbia University · USHerbert Irving Comprehensive Cancer Center

Funding

The Influence of Hospital Variability on the Management of Cancer-Associated CompR01CA169121 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WRIGHT, JASON · 2013 to 2017
$1.8M
Determinants and risks of use and overuse of expensive oncology drugsR01CA134964 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HERSHMAN, DAWN · 2008 to 2011
$1.0M
NCI NIH HHS R01 CA134964NCI NIH HHS R01 CA169121
6 · The paper itself

Abstract

backgroundLittle is known about the use and toxicity of antiadhesion substances such as sodium hyaluronate-carboxymethylcellulose.

objectiveWe analyzed the patterns of use and safety of sodium hyaluronate-carboxymethylcellulose in patients undergoing colectomy and gynecologic surgery.

designThis is a retrospective cohort study.

settingThis study covered hospitals nationwide. PATIENTS: All patients in the Premier Perspective database who underwent colectomy or hysterectomy from 2000 to 2010 were included in the analyses.

main outcome measureHyaluronate-carboxymethylcellulose use was determined by billing codes. For the primary outcome, we used hierarchical mixed-effects logistic regression models to determine the factors associated with the use of hyaluronate-carboxymethylcellulose, whereas a propensity score-matched analysis was used to secondarily assess the association between hyaluronate-carboxymethylcellulose use and toxicity (abscess, bowel and wound complications, peritonitis).

resultsWe identified 382,355 patients who underwent hysterectomy and 267,368 who underwent colectomy. For hysterectomy, hyaluronate-carboxymethylcellulose use was 5.0% overall, increasing from 1.1% in 2000 to 9.8% in 2010. Hyaluronate-carboxymethylcellulose was used in 8.1% of those who underwent colectomy and increased from 6.2% in 2000 to 12.4% in 2010. The year of diagnosis and procedure volume of the attending surgeon were the strongest predictors of hyaluronate-carboxymethylcellulose use. After matching and risk adjustment, hyaluronate-carboxymethylcellulose use was not associated with abscess formation (1.5% vs 1.5%) (relative risk = 0.97; 95% CI, 0.84-1.12) in those who underwent hysterectomy. A patient receiving hyaluronate-carboxymethylcellulose had a 13% increased risk of abscess (17.4% vs 15.0%) (relative risk = 1.13; 95% CI, 1.08-1.17) after colectomy. LIMITATIONS: This was an observational study.

conclusionHyaluronate-carboxymethylcellulose use has increased over the past decade for colectomy and hysterectomy. Although there is no association between hyaluronate-carboxymethylcellulose use and abscess following hysterectomy, hyaluronate-carboxymethylcellulose use was associated with a small increased risk of abscess after colectomy.

Indexed as

Membranes, ArtificialBiocompatible MaterialsCarboxymethylcellulose SodiumColectomyFemaleHospitalsHumansHyaluronic AcidHysterectomyLogistic ModelsMaleMiddle AgedPropensity ScoreRetrospective StudiesTime FactorsTissue AdhesionsBiocompatible MaterialsCarboxymethylcellulose SodiumHyaluronic AcidMembranes, Artificial

Identifiers

PMID24022535
PMCPMC4624422
OpenAlexW2052455367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.